SERUM ADENOSINE DEAMINASE LEVEL IN TYPE 2 DIABETIC PATIENTS AND ITS ASSOCIATION WITH HEMOGLOBIN A1C

Authors

  • Ramesh Kumar Suthar Bilawal Medical College, LUMHS, Jamshoro
  • Atif Ahmed Department of Medicine , Bilawal Medical College, LUMHS jamshoro
  • Kuldeep Kumar Poorani Department of Medicine , Bilawal Medical College, LUMHS jamshoro
  • Kashif Ali Department of Medicine, Bilawal Medical College, LUMHS ,Jamshoro
  • Ali Akbar Nangraj Department of Medicine, Bilawal Medical College, LUMHS, Jamshoro
  • Bedarbakhat Department of Medicine, LUMHS, Jamshoro

Keywords:

Adenosine deaminase, Ankle brachial index, Glycemic status, type 2 diabetes mellitus

Abstract

Background: Type 2 diabetes mellitus is a common metabolic disorder characterized by hyperglycemia. Elevated adenosine deaminase levels have been observed in diabetic individuals, but their relationship with glycemic control remains an area of interest. This study aims to investigate the serum adenosine deaminase levels in accord to the glycemic status and ABI in type 2 diabetic patients. Methods: This was a cross-sectional study was carried at Department of Medicine, DHQ Hospital Kotri from 06 December 2023 to 06 June 2024 after approval from research ethics committee. The study participants were 140 type 2 diabetic patients and they were categorized as uncontrolled (HbA1c > 7%) and controlled (HbA1c <7%). After informed consent, adenosine deaminase levels were measured in serum samples from both groups. The catered data was entered and analyzed in statistical software of IBM, SPSS version 22.0. Results:  The adenosine deaminase was compared according to glycemic status of diabetic patients, there was statistically significant increase in adenosine deaminase levels in patients with hemoglobin A 1c >7.0%. Conclusion: There is increase in adenosine deaminase with increase in hemoglobin A1C. A decrease in ABI is seen with increase in adenosine deaminse levels.

References

1. Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, et al. Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev 2001;21(2):105–28.

2. Flinn AM, Gennery AR. Adenosine deaminase deficiency: a review. Orphanet J Rare Dis 2018;13(1):65.

3. Niraula A, Thapa S, Kunwar S, Lamsal M, Baral N, Maskey R. Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role?. BMC Endocr Disord 2018;18(1):58.

4. Yu C, Zhuang L, Xu F, Zhao LH, Wang XH, Wang CH, et al. Increased levels of serum adenosine deaminase and increased risk of diabetic peripheral neuropathy in type 2 diabetes. Front Endocrinol (Lausanne) 2022;13:997672.

5. Lu CF, Ge XQ, Wang Y, Su JB, Wang XQ, Zhang DM, et al. The relationship between adenosine deaminase and heart rate-corrected QT interval in type 2 diabetic patients. Endocr Connect 2021;10(8):894-901.

6. Larijani B, Heshmat R, Ebrahimi-Rad M, Khatami S, Valadbeigi S, Saghiri R. Diagnostic Value of Adenosine Deaminase and Its Isoforms in Type II Diabetes Mellitus. Enzyme Res 2016;2016:9526593.

7. Hasan SU, Siddiqui MR. Nationwide prevalence of type 2 diabetes mellitus and pre-diabetes in Pakistan: A systematic review and meta-analysis. Diabetes Res Clin Pract 2024;216:111815.

8. Talebi Mehrdar M, Ebadi G. Increased levels of serum adenosine deaminase (ADA) enzyme and increased risk of T cell activation markers in type 2 diabetes. Cell Mol Biomed Rep 2024;4(3):159–67.

9. Kumar R, Chhatwal S, Arora S, Sharma S, Singh J, Singh N, et al. Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase–lowering effects of garlic in patients with type 2 diabetes mellitus with obesity. Diabetes Metab Syndr Obes 2013;6:49–56.

10. Cao J, Wang H, Su JB, Wang XQ, Zhang DM, Wang XH, et al. Inverse relationship between serum adenosine deaminase levels and islet beta cell function in patients with type 2 diabetes. Diabetol Metab Syndr 2021;13:54.

11. Kutryb-Zajac B, Mateuszuk L, Zukowska P, Jasztal A, Zabielska MA, Toczek M, et al. Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibition. Cardiovasc Res 2016;112(2):590–605.

12. Singh P, Khan S, Kumar MR. Adenosine deaminase activity and its relation with glycated hemoglobin and uric acid in type 2 diabetic patients. Iran J Diabetes Obes 2013;5(1):1–6.

13. Khemka VK, Bagchi D, Ghosh A, Sen O, Bir A, Chakrabarti S, et al. Raised serum adenosine deaminase level in nonobese type 2 diabetes mellitus. Sci World J 2013;2013:404320.

14. Sapkota LB, Thapa S, Subedi N. Correlation study of adenosine deaminase and its isoenzymes in type 2 diabetes mellitus. BMJ Open Diabetes Res Care 2017;5(1):e000357.

15. Furuhashi M. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity. Am J Physiol Endocrinol Metab 2020;319(5):E827–34

Published

2026-05-21

How to Cite

1.
Suthar RK, Atif Ahmed, Kuldeep Kumar Poorani, Kashif Ali, Ali Akbar Nangraj, Bedarbakhat. SERUM ADENOSINE DEAMINASE LEVEL IN TYPE 2 DIABETIC PATIENTS AND ITS ASSOCIATION WITH HEMOGLOBIN A1C. J Ayub Med Coll Abbottabad [Internet]. 2026 May 21 [cited 2026 May 22];37(4). Available from: https://jamc.ayubmed.edu.pk/index.php/jamc/article/view/13962

Issue

Section

ORIGINAL ARTICLE